Skip to main content
LGND logo

LGND

Ligand Pharmaceuticals Inc
$296.26 -4.71 (-1.56%) At close · Jul 15
Market Cap
$5.99B
Shares
20,041,061

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 363
Total Value: $4,074,593,959
Total Shares: 19,965,329
Showing 1–100 of 370 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 357 13F filers
Top Holder
15.0%
Jun 2023 → Mar 2026 · range 14.3% – 43.4%
of institutional value
Top 5
32.5%
Jun 2023 → Mar 2026 · range 32.5% – 62.0%
of institutional value
Top 10
47.0%
Jun 2023 → Mar 2026 · range 47.0% – 70.5%
of institutional value
HHI
399
Jun 2023 → Mar 2026 · range 399 – 2,024
Broadly held
Showing 100 of 370
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 886163 CUSIP 53220K504 13F (30d) 32 filings 28 filers Visit website Investor relations